Marker Therapeutics Inc (NASDAQ: MRKR) on Monday, plunged -10.00% from the previous trading day, before settling in for the closing price of $1.7. Within the past 52 weeks, MRKR’s price has moved between $0.95 and $5.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 23.96% over the past five years. The company achieved an average annual earnings per share of -32.35%. With a float of $7.90 million, this company’s outstanding shares have now reached $11.21 million.
Let’s look at the performance matrix of the company that is accounted for 5 employees. In terms of profitability, gross margin is 100.0%, operating margin of -231.35%, and the pretax margin is -223.57%.
Marker Therapeutics Inc (MRKR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Marker Therapeutics Inc is 30.21%, while institutional ownership is 17.29%. The most recent insider transaction that took place on Dec 23 ’24, was worth 35,472. In this transaction Director of this company bought 11,085 shares at a rate of $3.20, taking the stock ownership to the 325,370 shares. Before that another transaction happened on Dec 23 ’24, when Company’s 10% Owner bought 554,250 for $3.20, making the entire transaction worth $1,773,600. This insider now owns 1,625,678 shares in total.
Marker Therapeutics Inc (MRKR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -32.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.40% during the next five years compared to 23.96% growth over the previous five years of trading.
Marker Therapeutics Inc (NASDAQ: MRKR) Trading Performance Indicators
Marker Therapeutics Inc (MRKR) is currently performing well based on its current performance indicators. A quick ratio of 6.79 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.33, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.78 in one year’s time.
Technical Analysis of Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc (NASDAQ: MRKR) saw its 5-day average volume 13.17 million, a positive change from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 9.32%.
During the past 100 days, Marker Therapeutics Inc’s (MRKR) raw stochastic average was set at 18.59%, which indicates a significant increase from 4.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3046 in the past 14 days, which was higher than the 0.1576 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4570, while its 200-day Moving Average is $2.1959.